BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16257978)

  • 1. A method to find tissue-specific novel sites of selective adenosine deamination.
    Ohlson J; Ensterö M; Sjöberg BM; Ohman M
    Nucleic Acids Res; 2005 Oct; 33(19):e167. PubMed ID: 16257978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for finding sites of selective adenosine deamination.
    Ohlson J; Ohman M
    Methods Enzymol; 2007; 424():289-300. PubMed ID: 17662846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of substrates for adenosine deaminases that act on RNA.
    Morse DP
    Methods Mol Biol; 2004; 265():199-218. PubMed ID: 15103075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine.
    Yang JH; Sklar P; Axel R; Maniatis T
    Nature; 1995 Mar; 374(6517):77-81. PubMed ID: 7870177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-selective versus promiscuous A-to-I editing.
    Wahlstedt H; Ohman M
    Wiley Interdiscip Rev RNA; 2011; 2(6):761-71. PubMed ID: 21976281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editing modifies the GABA(A) receptor subunit alpha3.
    Ohlson J; Pedersen JS; Haussler D; Ohman M
    RNA; 2007 May; 13(5):698-703. PubMed ID: 17369310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new targets of Drosophila pre-mRNA adenosine deaminase.
    Xia S; Yang J; Su Y; Qian J; Ma E; Haddad GG
    Physiol Genomics; 2005 Jan; 20(2):195-202. PubMed ID: 15522950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-to-I editing challenger or ally to the microRNA process.
    Ohman M
    Biochimie; 2007 Oct; 89(10):1171-6. PubMed ID: 17628290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching active site and substrate structures for an RNA editing reaction.
    Pokharel S; Jayalath P; Maydanovych O; Goodman RA; Wang SC; Tantillo DJ; Beal PA
    J Am Chem Soc; 2009 Aug; 131(33):11882-91. PubMed ID: 19642681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for functional adenosine to inosine RNA editing systems.
    Pokharel S; Beal PA
    ACS Chem Biol; 2006 Dec; 1(12):761-5. PubMed ID: 17240974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.
    Higuchi M; Maas S; Single FN; Hartner J; Rozov A; Burnashev N; Feldmeyer D; Sprengel R; Seeburg PH
    Nature; 2000 Jul; 406(6791):78-81. PubMed ID: 10894545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of editors at the novel A-to-I editing positions.
    Nishimoto Y; Yamashita T; Hideyama T; Tsuji S; Suzuki N; Kwak S
    Neurosci Res; 2008 Jun; 61(2):201-6. PubMed ID: 18407364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
    Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
    Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase.
    Polson AG; Bass BL; Casey JL
    Nature; 1996 Apr; 380(6573):454-6. PubMed ID: 8602246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs.
    Maydanovych O; Easterwood LM; Cui T; Véliz EA; Pokharel S; Beal PA
    Methods Enzymol; 2007; 424():369-86. PubMed ID: 17662850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic and bioinformatic approaches for the identification of new adenosine-to-inosine substrates.
    Sixsmith J; Reenan RA
    Methods Enzymol; 2007; 424():245-64. PubMed ID: 17662844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity.
    Stephens OM; Haudenschild BL; Beal PA
    Chem Biol; 2004 Sep; 11(9):1239-50. PubMed ID: 15380184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.